Table of Contents
ISRN Infectious Diseases
Volume 2013, Article ID 759208, 6 pages
http://dx.doi.org/10.5402/2013/759208
Review Article

Resistance of Gram-Negative Bacilli in Lebanon

Clinical Microbiology, Department of Biomedical Sciences, Faculty of Medicine & Medical Sciences, University of Balamand, P.O. Box 100, Tripoli, Lebanon

Received 14 April 2012; Accepted 5 June 2012

Academic Editors: J.-M. Bart, C.-K. Fan, and A. P. Gibb

Copyright © 2013 S. E. Salem et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. B. Schofield, “The anarchy of antibiotic resistance: mechanisms of bacterial resistance,” MLO: Medical Laboratory Observer, vol. 43, no. 5, pp. 10–19, 2011. View at Google Scholar · View at Scopus
  2. D. M. Livermore, “Bacterial resistance: origins, epidemiology, and impact,” Clinical Infectious Diseases, vol. 36, no. 1, supplement, pp. S11–S23, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Gaynes, J. R. Edwards, and National Nosocomial Infections Surveillance System, “Overview of nosocomial infections caused by gram-negative bacilli,” Clinical Infectious Diseases, vol. 41, no. 6, pp. 848–854, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. F. C. Tenover, “Mechanisms of antimicrobial resistance in bacteria,” American Journal of Infection Control, vol. 34, no. 5, pp. S3–S10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Diekema, M. A. Pfaller, R. N. Jones et al., “Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997,” Clinical Infectious Diseases, vol. 29, no. 3, pp. 595–607, 1999. View at Google Scholar · View at Scopus
  6. Z. Daoud and C. Afif, “Escherichia coli isolated from urinary tract infections of lebanese patients between 2000 and 2009: epidemiology and profile of resistance,” Chemotherapy Research and Practice, vol. 2011, Article ID 218431, 6 pages, 2011. View at Publisher · View at Google Scholar
  7. T. Naas, G. Cuzon, P. Bogaerts, Y. Glupczynski, and P. Nordmann, “Evaluation of a DNA microarray (check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases,” Journal of Clinical Microbiology, vol. 49, no. 4, pp. 1608–1613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Livermore and N. Woodford, “The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter,” Trends in Microbiology, vol. 14, no. 9, pp. 413–420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. E. Falagas and D. E. Karageorgopoulos, “Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: need for international harmonization in terminology,” Clinical Infectious Diseases, vol. 46, no. 7, pp. 1121–1122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. J. Rahal, C. Urban, D. Horn et al., “Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella,” Journal of the American Medical Association, vol. 280, no. 14, pp. 1233–1237, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. A. Kanafani, A. Mehio-Sibai, G. F. Araj, M. Kanaan, and S. S. Kanj, “Epidemiology and risk factors for extended-spectrum β-lactamase- producing organisms: a case control study at a tertiary care center in Lebanon,” American Journal of Infection Control, vol. 33, no. 6, pp. 326–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Borg, P. Zarb, M. Ferech, and H. Goossens, “Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 4, pp. 830–836, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Fadel, G. K. Dakdouki, Z. A. Kanafani, G. F. Araj, and S. S. Kanj, “Clinical and microbiological profile of urinary tract infection at a tertiary-care center in Lebanon,” Infection Control and Hospital Epidemiology, vol. 25, no. 1, pp. 82–85, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Daoud, C. Moubareck, N. Hakime, and F. Doucet-Populaire, “Extended spectrum β-lactamase producing Enterobacteriaceae in Lebanese ICU patients: epidemiology and patterns of resistance,” Journal of General and Applied Microbiology, vol. 52, no. 3, pp. 169–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Borg, E. Scicluna, M. de Kraker et al., “Antibiotic resistance in the southeastern Mediterranean—preliminary results from the ARMed project,” Euro Surveillance, vol. 11, no. 7, pp. 164–167, 2006. View at Google Scholar · View at Scopus
  16. M. A. Borg, N. Van De Sande-Bruinsma, E. Scicluna et al., “Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories,” Clinical Microbiology and Infection, vol. 14, no. 8, pp. 789–796, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Moubareck, Z. Daoud, N. I. Hakimé et al., “Countrywide spread of community- and hospital-acquired extended-spectrum β-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon,” Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3309–3313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. R. Lockhart, M. A. Abramson, S. E. Beekmann et al., “Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004,” Journal of Clinical Microbiology, vol. 45, no. 10, pp. 3352–3359, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. D. L. Paterson, “Resistance in gram-negative bacteria: Enterobacteriaceae,” American Journal of Infection Control, vol. 34, no. 5, pp. S20–S28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. G. F. Araj, M. M. Uwaydah, and S. Y. Alami, “Antimicrobial susceptibility patterns of bacterial isolates at the American University Medical Center in Lebanon,” Diagnostic Microbiology and Infectious Disease, vol. 20, no. 3, pp. 151–158, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. G. F. Araj and G. Y. Ibrahim, “Tigecycline in vitro activity against commonly encountered multidrug-resistant Gram-negative pathogens in a Middle Eastern country,” Diagnostic Microbiology and Infectious Disease, vol. 62, no. 4, pp. 411–415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. N. Samaha-Kfoury and G. F. Araj, “Recent developments in β lactamases and extended spectrum β lactamases,” British Medical Journal, vol. 327, no. 7425, pp. 1209–1213, 2003. View at Google Scholar · View at Scopus
  23. P. A. Bradford, “Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat,” Clinical Microbiology Reviews, vol. 14, no. 4, pp. 933–951, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Rishi, P. Dhillon, and J. Clark, “ESBLs: a clear and present danger?” Critical Care Research and Practice, vol. 2012, Article ID 625170, 11 pages, 2012. View at Google Scholar
  25. Z. Daoud and N. Hakime, “Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon,” Revista Espanola de Quimioterapia, vol. 16, no. 2, pp. 233–238, 2003. View at Google Scholar · View at Scopus
  26. Z. K. Otrock, G. O. Oghlakian, M. M. Salamoun, M. Haddad, and A. R. N. Bizri, “Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon,” Infection Control and Hospital Epidemiology, vol. 25, no. 10, pp. 873–877, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. A. Kanafani, L. Kara, S. Hayek, and S. S. Kanj, “Ventilator-associated Pneumonia at a tertiary-care center in a developing country: incidence, microbiology, and susceptibility patterns of isolated microorganisms,” Infection Control and Hospital Epidemiology, vol. 24, no. 11, pp. 864–869, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Tohmé, D. Karam-Sarkis, R. El-Rassi, D. Chélala, and E. Ghayad, “Agents and consequences of nosocomial bacterial infections in a Lebanese university hospital. Retrospective over a two-year period,” Annales de Medecine Interne, vol. 152, no. 2, pp. 77–83, 2001. View at Google Scholar · View at Scopus
  29. A. El Kholy, H. Baseem, G. S. Hall, G. W. Procop, and D. L. Longworth, “Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals,” Journal of Antimicrobial Chemotherapy, vol. 51, no. 3, pp. 625–630, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. N. Samaha-Kfoury, S. S. Kanj, and G. F. Araj, “In vitro activity of antimicrobial agents against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon,” American Journal of Infection Control, vol. 33, no. 3, pp. 134–136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. G. M. Matar, I. Dandache, A. Carrër et al., “Spread of OXA-48-mediated resistance to carbapenems in Lebanese Klebsiella pneumoniae and Escherichia coli that produce extended spectrum β-lactamase,” Annals of Tropical Medicine and Parasitology, vol. 104, no. 3, pp. 271–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. T. J. Shaar and R. Al-Hajjar, “Antimicrobial susceptibility patterns of bacteria at the Makassed General Hospital in Lebanon,” International Journal of Antimicrobial Agents, vol. 14, no. 2, pp. 161–164, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. S. S. Kanj, J. E. Corkill, Z. A. Kanafani et al., “Molecular characterisation of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates at a tertiary-care centre in Lebanon,” Clinical Microbiology and Infection, vol. 14, no. 5, pp. 501–504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. M. H. Nicolas-Chanoine, J. Blanco, V. Leflon-Guibout et al., “Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 2, pp. 273–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Daoud, E. Hobeika, A. Choucair, and R. Rohban, “Isolation of the first metallo-β-lactamase producing Klebsiella pneumoniae in Lebanon,” Revista Espanola de Quimioterapia, vol. 21, no. 2, pp. 123–126, 2008. View at Google Scholar · View at Scopus
  36. G. M. Matar, G. Cuzon, G. F. Araj et al., “Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon,” Clinical Microbiology and Infection, vol. 14, no. 9, pp. 887–888, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Benouda, O. Touzani, M. T. Khairallah, G. F. Araj, and G. M. Matar, “First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco,” Annals of Tropical Medicine and Parasitology, vol. 104, no. 4, pp. 327–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Nordmann, G. Cuzon, and T. Naas, “The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria,” The Lancet Infectious Diseases, vol. 9, no. 4, pp. 228–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Harakeh, H. Yassine, M. Gharios et al., “Isolation, molecular characterization and antimicrobial resistance patterns of Salmonella and Escherichia coli isolates from meat-based fast food in Lebanon,” Science of the Total Environment, vol. 341, no. 1–3, pp. 33–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. N. M. Hanna, S. M. Adib, and Z. D. Daoud, “Food-borne salmonella outbreak at a bank cafeteria: an investigation in an Arab country in transition,” Eastern Mediterranean Health Journal, vol. 15, no. 2, pp. 470–474, 2009. View at Google Scholar · View at Scopus
  41. C. Moubareck, F. Doucet-Populaire, M. Hamze, Z. Daoud, and F. X. Weill, “First extended-spectrum-β-lactamase (CTX-M-15)-producing Salmonella enterica serotype typhimurium isolate identified in Lebanon,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 2, pp. 864–865, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Karim, L. Poirel, S. Nagarajan, and P. Nordmann, “Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1,” FEMS Microbiology Letters, vol. 201, no. 2, pp. 237–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. G. M. Matar, R. Jaafar, A. Sabra et al., “First detection and sequence analysis of the bla-CTX-M-15 gene in Lebanese isolates of extended-spectrum-β-lactamase-producing Shigella sonnei,” Annals of Tropical Medicine and Parasitology, vol. 101, no. 6, pp. 511–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. H. Sabra, G. F. Araj, M. M. Kattar et al., “Molecular characterization of ESBL-producing Shigella sonnei isolates from patients with bacilliary dysentery in Lebanon,” Journal of Infection in Developing Countries, vol. 3, no. 4, pp. 300–305, 2009. View at Google Scholar · View at Scopus
  45. K. Ekdahl and Y. Andersson, “The epidemiology of travel-associated shigellosis-regional risks, seasonality and serogroups,” Journal of Infection, vol. 51, no. 3, pp. 222–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. A. B. Lang, M. P. Horn, M. A. Imboden, and A. W. Zuercher, “Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients,” Vaccine, vol. 22, no. 1, pp. S44–S48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. A. J. Morrison and R. P. Wenzel, “Epidemiology of infections due to Pseudomonas aeruginosa,” Reviews of Infectious Diseases, vol. 6, pp. S627–S642, 1984. View at Google Scholar · View at Scopus
  48. G. M. Matar, M. H. Chaar, G. F. Araj, Z. Srour, G. Jamaleddine, and U. Hadi, “Detection of a highly prevalent and potentially virulent strain of Pseudomonas aeruginosa from nosocomial infections in a medical center,” BMC Microbiology, vol. 5, article 29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Pournaras, A. Markogiannakis, A. Ikonomidis et al., “Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit,” Journal of Antimicrobial Chemotherapy, vol. 57, no. 3, pp. 557–561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Giannouli, F. Tomasone, A. Agodi et al., “Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals,” Journal of Antimicrobial Chemotherapy, vol. 63, no. 4, pp. 828–830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Zarrilli, D. Vitale, A. Di Popolo et al., “A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 11, pp. 4115–4120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. D. J. Weber, R. Raasch, and W. A. Rutala, “Nosocomial infections in the ICU: the growing importance of antibiotic- resistant pathogens,” Chest, vol. 115, no. 3, pp. 34S–41S, 1999. View at Google Scholar · View at Scopus
  53. R. Sharma, C. L. Sharma, and B. Kapoor, “Antibacterial resistance: current problems and possible solutions,” Indian Journal of Medical Sciences, vol. 59, no. 3, pp. 120–129, 2005. View at Google Scholar · View at Scopus
  54. E. K. Barbour, M. Al Sharif, V. K. Sagherian, A. N. Habre, R. S. Talhouk, and S. N. Talhouk, “Screening of selected indigenous plants of Lebanon for antimicrobial activity,” Journal of Ethnopharmacology, vol. 93, no. 1, pp. 1–7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Abdel-Massih, E. Abdou, E. Baydoun, and Z. Daoud, “Antibacterial activity of the extracts obtained from Rosmarinus officinalis, Origanum majorana, and Trigonella foenum-graecum on highly drug-resistant gram negative bacilli,” Journal of Botany, vol. 2010, Article ID 464087, 8 pages, 2010. View at Publisher · View at Google Scholar